Haemonetics Corporation reported earnings results for the second quarter and six months ended October 01, 2022. For the second quarter, the company reported sales was USD 258.8 million compared to USD 239.9 million a year ago. Net income was USD 33.2 million compared to USD 14.86 million a year ago. Diluted earnings per share from continuing operations was USD 0.64 compared to USD 0.29 a year ago.
For the six months, sales was USD 558.94 million compared to USD 468.43 million a year ago. Net income was USD 53.07 million compared to USD 10.4 million a year ago. Diluted earnings per share from continuing operations was USD 1.03 compared to USD 0.2 a year ago.